No abstract available
MeSH terms
-
Androgen Antagonists / therapeutic use
-
Chemotherapy, Adjuvant
-
Disease-Free Survival
-
Humans
-
Male
-
Neoplasm Recurrence, Local / prevention & control*
-
Nephrectomy / methods*
-
Prognosis
-
Prostate-Specific Antigen / blood*
-
Prostatic Neoplasms / pathology
-
Prostatic Neoplasms / therapy*
-
Radiotherapy, Adjuvant
-
Randomized Controlled Trials as Topic
-
Risk Assessment
-
Time Factors
-
Treatment Outcome
Substances
-
Androgen Antagonists
-
Prostate-Specific Antigen